Lv11
30 积分 2021-08-09 加入
Optimal treatment strategy for recurrent hepatocellular carcinoma based on recurrence time and tumor size: A propensity score matching study
7小时前
待确认
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach
6个月前
已完结
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial
6个月前
已完结
Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial
8个月前
已完结
Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial
8个月前
已完结
Biomarkers of Pathologic Complete Response to Neoadjuvant Immunotherapy in Mismatch Repair–Deficient Colorectal Cancer
8个月前
已完结
Current developments in gastric cancer: from molecular profiling to treatment strategy
9个月前
已完结
A Burning External Colon Cancer Patient With Diffuse Miliary Peritoneal Metastases
10个月前
已完结
The emerging role of pyroptosis in neuropathic pain
10个月前
已完结
Transcriptomics and metabolomics revealed the molecular mechanism of the toxic effect of mancozeb on liver of mice
10个月前
已完结
皖公网安备34019202002308
